A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer

Stopped The trial was terminated for strategic reasons. The decision was not based on any safety and/or efficacy concerns.

Conditions

• Urinary Bladder Neoplasms
• Bladder Cancer
• Bladder Tumors
• Urothelial Carcinoma

Interventions

• DRUG: Avelumab first-line maintenance

Sponsor

Pfizer